Huyen Tran

OverviewAI-generated summary

Huyen Tran's research focuses on hematological disorders, particularly hemophilia and thrombosis. Tran is the Director of the Haemophilia Treatment Centre and Head of the Haemostasis Thrombosis Unit at the University of Arkansas at Fayetteville. Their work involves investigating the efficacy and safety of novel treatments for hemophilia, including studies on drugs like fitusiran and concizumab in patients with inhibitors.

Tran's research also extends to understanding and managing vaccine-induced immune thrombotic thrombocytopenia (VITT), a condition that emerged following certain COVID-19 vaccinations. This includes developing diagnostic and management strategies and comparing immune responses to different vaccine types. Their publication record demonstrates a commitment to both clinical trials and the study of immune responses to viral vectors and mRNA vaccines. With an h-index of 30 and over 220 publications, Tran is recognized as a highly cited researcher.

Collaborative efforts are a significant aspect of Tran's work, evidenced by shared publications with colleagues such as Kim Hoang Tran, Duy Anh, and Pha Nguyen, all affiliated with the University of Arkansas at Fayetteville. These collaborations likely contribute to the breadth and depth of research conducted within the institution.

Metrics

• h-index: 30
• Publications: 220
• Citations: 3,911